Glucose Metabolism After Partial Pancreatectomy
Alteration of Glucose Metabolism After Partial Pancreatectomy Assessed With Biochemical Markers :A Single Center Prospective Observational Study
1 other identifier
observational
224
0 countries
N/A
Brief Summary
This is a single center observational study to assess alteration of glucose metabolism after pancreatectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2020
CompletedFirst Submitted
Initial submission to the registry
May 26, 2020
CompletedFirst Posted
Study publicly available on registry
June 1, 2020
CompletedJune 1, 2020
May 1, 2020
3.3 years
May 26, 2020
May 26, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
incidence & risk factors of new-onset DM
incidence \& risk factors of new onset DM after pancreatectomy
at 1 year
incidence & risk factors of worsened DM
incidence \& risk factors of worsened DM after pancreatectomy
at 1 year
Secondary Outcomes (1)
characteristics of new-onset and worsened DM
1 year
Study Arms (2)
PD
pancreaticoduodenectomy
DP
distal pancreatectomy
Interventions
Eligibility Criteria
patients receiving partial pancreatectomy
You may qualify if:
- partial pancreatectomy
You may not qualify if:
- total pancreatectomy
- incomplete testing
- follow-up loss
- death within 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Lee BW, Kang HW, Heo JS, Choi SH, Kim SY, Min YK, Chung JH, Lee MK, Lee MS, Kim KW. Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy. Metabolism. 2006 Jan;55(1):135-41. doi: 10.1016/j.metabol.2005.08.005.
PMID: 16324932BACKGROUNDHwang HK, Park J, Choi SH, Kang CM, Lee WJ. Predicting new-onset diabetes after minimally invasive subtotal distal pancreatectomy in benign and borderline malignant lesions of the pancreas. Medicine (Baltimore). 2017 Dec;96(51):e9404. doi: 10.1097/MD.0000000000009404.
PMID: 29390555BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 26, 2020
First Posted
June 1, 2020
Study Start
September 1, 2015
Primary Completion
December 31, 2018
Study Completion
January 31, 2020
Last Updated
June 1, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share
There are no plans of sharing IPD